Delivery Order SPE2DB22D1202-SPE2DB24FUWP5
Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract, valued at $16,219.06, has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 380 mg VIVITROL vials and diluents. The $2,798.10 contract has a completion date of February 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not associated with any set-aside program. This award is part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIVITROL 380 MG VIAL-DILUENTS. The contract has a potential value of $1,828.64 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization located in Conshohocken, Pennsylvania, is the prime contractor on this award. The contract does not have a set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The $5,485.92 contract has a completion date of July 29, 2024 and is not set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential pharmaceutical and medical supplies to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,032.25, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, which has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $2,610.24, is for the delivery of Vivitrol 380 mg vials with diluents. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $5,817.72 and a period of performance through April 3, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is a delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
- The Defense Logistics Agency awarded a delivery order valued at $36,064.28 to AmerisourceBergen Drug Corp for VIVITROL 380 mg vial-diluents. The contract, executed on February 4, 2026, carries a firm fixed-price structure with an ultimate completion date of February 5, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is issued under...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm fixed price delivery order has a potential value of $1,828.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp, as the prime contractor, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUWP5Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D1202|SPE2DB24FUWP5) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VIVITROL 380 MG VIAL-DILUENTS. The $10,971.72 contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract the company holds with DLA to supply pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities. No set-aside designation was used for this award.
Generated 7/11/24, 9:24 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 4/11/24 |